Literature DB >> 17013480

Neurological manifestations of Behçet's disease.

Afshin Borhani-Haghighi1, Shahdokht Samangooie, Nahid Ashjazadeh, Alireza Nikseresht, Abdolhamid Shariat, Gholamali Yousefipour, Anahid Safari.   

Abstract

OBJECTIVE: To determine the prevalence, clinical manifestations, and laboratory features of Neuro-Behçet's disease.
METHODS: This prospective study was carried out in the Behçet's Research Clinic in Shiraz (south-west Iran) and included the patients referred from 1990-1999. The patients' clinical records, images, CSF analyses, and electrodiagnostic studies were reviewed.
RESULTS: Eighteen (15 males and 3 females) out of 690 Behcet s patients (2.6%, 95% CI = 1.4-3.8%) were found to have neurological involvement. The mean +/- standard deviation age of these patients was 34.7 +/- 8.6 years. All fulfilled the criteria of the International Study Group of Behcet s Disease. Central nervous system involvement was more common than peripheral nervous system manifestations. Headache, weakness, tingling, and numbness were the most common symptoms. Hyperreflexia, upward plantar reflex, and somatosensory findings were the most frequent signs. Hemispheral and brainstem stroke-like syndromes and cerebral venous thrombosis were the major neurologic presentations. There were also cases of myelitic, pure meningoencephalitic, amyotrophic lateral sclerosis-like, multiple sclerosis-like, and Guillain Barre syndromes.
CONCLUSION: Neuro-Behçet's disease must be considered in the differential diagnosis of stroke in young adults, chronic meningitis, intracranial hypertension, multiple sclerosis, myelopathies, and peripheral neuropathies.

Entities:  

Mesh:

Year:  2006        PMID: 17013480

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  11 in total

1.  Comment on "cerebral venous thrombosis in Behcet's disease: a systematic review".

Authors:  Afshin Borhani-Haghighi; Anahid Safari
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

2.  A Patient with Neuro-Behçet's Syndrome Presenting with Peripheral Nerve Involvement.

Authors:  Dilcan Kotan; Murat Alemdar; Semra Alaçam Köksal
Journal:  Noro Psikiyatr Ars       Date:  2017-12       Impact factor: 1.339

3.  MRI findings of neuro-Behcet's disease.

Authors:  Afshin Borhani Haghighi; Sirous Sarhadi; Siamak Farahangiz
Journal:  Clin Rheumatol       Date:  2010-12-18       Impact factor: 2.980

4.  Proposing an algorithm for treatment of different manifestations of neuro-Behcet's disease.

Authors:  Afshin Borhani Haghighi; Anahid Safari
Journal:  Clin Rheumatol       Date:  2010-03-13       Impact factor: 2.980

5.  Association of amyotrophic lateral sclerosis and Behcet's disease: is there a relationship? A multi-national case series.

Authors:  Hela Mrabet; Afshin Borhani-Haghighi; Emel Koseoglu; Melike Mutlu; Recep Baydemir; Shahriar Nafissi; Slim Eschebbi; Emel Delibas; Shahdokht Samangooie; Fatih Yetkin; Amel Mrabet; Yesim Parman; Seyed Taghi Heydari; Gulsen Akman-Demir
Journal:  Clin Rheumatol       Date:  2012-01-11       Impact factor: 2.980

Review 6.  Cerebral venous thrombosis in Behçet's disease: a systematic review.

Authors:  D Aguiar de Sousa; T Mestre; J M Ferro
Journal:  J Neurol       Date:  2011-01-06       Impact factor: 4.849

Review 7.  Infliximab for patients with neuro-Behcet's disease: case series and literature review.

Authors:  Afshin Borhani Haghighi; Anahid Safari; Mohammad Ali Nazarinia; Zahra Habibagahi; Saeedeh Shenavandeh
Journal:  Clin Rheumatol       Date:  2011-03-24       Impact factor: 2.980

8.  CNS diseases and uveitis.

Authors:  Pia Allegri; Roberto Rissotto; Carl P Herbort; Ugo Murialdo
Journal:  J Ophthalmic Vis Res       Date:  2011-10

9.  Cerebral venous-sinus thrombosis: a case series analysis.

Authors:  Nahid Ashjazadeh; Afshin Borhani Haghighi; Maryam Poursadeghfard; Hoseinjan Azin
Journal:  Iran J Med Sci       Date:  2011-09

10.  Clinical characteristics and prognosis of Neuro-Behçet's disease.

Authors:  Mine Hayriye Sorgun; Mustafa Aykut Kural; Canan Yücesan
Journal:  Eur J Rheumatol       Date:  2018-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.